Marvell Surges on Bullish 2031 Revenue Target, But Valuation Risks Loom

What happened

Marvell Technology shares rallied 6.5% to $288.94 on October 6, 2026, after management projected fiscal 2031 revenue between $70 billion and $90 billion, with a midpoint of $80 billion that is nearly double the Visible Alpha consensus of $46.85 billion. The long-term forecast signals confidence in sustained AI-driven demand for custom silicon, optics, and switching, building on the company's recent execution where Q1 FY27 revenue rose 28% year-over-year to $2.418 billion. However, the stock now trades at levels that already embed aggressive growth assumptions, at roughly 97x trailing earnings and far above the $260 trim level identified in our August analysis. The reaction appears driven by the sheer size of the revenue target relative to consensus, rather than incremental evidence of near-term contract conversions or production ramps. Given the crowded AI semiconductor trade and the company's history of lumpy custom program revenue, investors should treat the 2031 target as aspirational rather than a baseline.

Implication

The bullish 2031 forecast does not change the core risk: Marvell must convert its design wins and product sampling into production revenue across multiple hyperscaler programs, a process that remains unproven at scale. At $288.94, the market cap implies a multiple that already prices in near-perfect execution, while the company's valuation was already stretched at 75.4x P/E and 43.1x EV/EBITDA as of early August. Investors should wait for evidence in the next few quarterly reports that Q2 FY27 revenue meets the $2.7B guide and that custom silicon and switching ramps are on schedule before adding exposure. A pullback toward $185–$200 would offer a more attractive entry, aligning with our scenario analysis where base-case intrinsic value is around $225. Until then, we maintain our WAIT rating and recommend trimming positions above $260, as the risk/reward is skewed unfavorably after this surge.

Thesis delta

The long-term revenue target of $80 billion midpoint for fiscal 2031 is significantly above consensus and suggests management sees a larger AI TAM than previously modeled, potentially driven by broader custom silicon and connectivity adoption. However, this does not alter our near-term view that valuation already reflects upside, and we still require execution evidence before upgrading. The stock's surge above $260 actually strengthens our conviction to trim, as it now exceeds our trim threshold by a wide margin.